MarketPulse — Real-Time Financial News & Market Analysis

Law firm investigates Alvotech after FDA rejected applications following failed facility inspection, causing stock to plunge 34%. Investors sought for potential securities litigation.

Navan faces securities fraud lawsuit over IPO disclosure gaps regarding undisclosed sales expenses and slowing revenue growth. Stock fell 48% since offering.

TPL stock rose on analyst upgrade recognizing power generation opportunity. KeyBanc raised price target to $639, citing AI data center infrastructure potential on Permian Basin lands.

Class action investigations launched against Ramaco Resources and Beyond Meat for alleged securities violations. Investors face deadlines of March 31 and March 24, 2026, respectively, to petition as lead plaintiffs.

Class action lawsuit filed against Navan alleging IPO disclosure failures on sales and marketing costs. Stock fell 64% from $25 to $9.01 since offering.

Tesla's robotaxi fleet shows crash rates 4-8 times higher than human drivers, with only 42 vehicles operating. Regulatory challenges and high stock valuations intensify pressure on autonomous ambitions.

Alight shares plummeted after BofA downgraded the stock, citing weak Q4 earnings and cautious 2026 guidance. Revenue projections and retention metrics disappointed investors.

Tesla slashes Cybertruck price to $59,990 for 10 days to gauge demand amid a 49% sales decline, using response to set permanent pricing strategy.

Corcept Therapeutics faces class action lawsuit for allegedly misleading statements about relacorilant's clinical evidence. FDA rejected the drug application, causing stock to plummet 50%.

Ostin Technology faces class action lawsuit alleging securities fraud scheme involving fraudulent offerings and stock price manipulation that netted $110 million before collapsing 94%.

Opendoor accelerated inventory turnover, purchasing 46% more homes sequentially while cutting extended-stay inventory from 51% to 33%, signaling improved operational efficiency and profitability.

Supernus Pharmaceuticals will present at three major healthcare conferences in March 2026, updating investors on strategic initiatives and operational progress.

Nvidia's valuation hits 12-month low at 24x forward earnings. Historical patterns suggest potential upside, though $4.6 trillion market cap may limit gains despite strong fundamentals.

FDA places partial clinical hold on MacroGenics' LINNET trial due to serious adverse events including thrombocytopenia, myocarditis, and one death. New enrollment halted.

Douglas Dynamics achieved 15% revenue growth and 52% EPS surge in 2025, driven by favorable winter weather and operational efficiency. Company expects continued momentum in 2026.

Chicago Rivet & Machine maintains its quarterly dividend at $0.03 per share, payable March 20, 2026. Future dividends remain contingent on profitability and cash flow.

BlackRock Canada announces final February distribution of $0.088 per unit for CMR Money Market Fund, payable February 27 to unitholders of record as of February 24.

Masonite faces securities fraud lawsuit for allegedly hiding Owens Corning acquisition talks while repurchasing stock. Investors have until April 2026 to join class action.

Law firm investigates Gemini Space Station after three senior executives abruptly resigned, causing stock to plummet 12.83%. Probe examines potential securities law violations.

Rosen Law Firm investigates Lufax for potential disclosure violations after auditor removal announcement triggered 13.8% stock decline. Class action lawsuit evaluation ongoing.